PharmaCyte Biotech
PMCB · NASDAQ
$0.3422+$0.0002 (+0.06%)TodayMarket closed ·
Prev close $0.342
Who owns PMCB
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 10.7% of PMCB’s shares.
- Silverman (Joshua)3.4%
- Citadel Advisors LLC2.6%
- Schechter (Jonathan L)1.2%
- Geode Capital Management, L.L.C.1.2%
- Next 6 largest institutions2.3%
- All other shareholders89.3%
| Holder | Shares | % of shares |
|---|---|---|
| Silverman (Joshua) | 366.25K | 3.41% |
| Citadel Advisors LLC | 283.38K | 2.64% |
| Schechter (Jonathan L) | 132.50K | 1.23% |
| Geode Capital Management, L.L.C. | 124.25K | 1.16% |
| Vanguard Capital Management, LLC | 56.78K | 0.53% |
| Susquehanna International Group, LLP | 44.85K | 0.42% |
| Weinstein (Robert) | 41.25K | 0.38% |
| Renaissance Technologies LLC | 37.99K | 0.35% |
| XTX Markets LLC | 34.18K | 0.32% |
| Northern Trust Investments, Inc. | 32.62K | 0.30% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Extended Market Index Fund | 58.55K | 0.55% |
| Vanguard Extended Market Index Fund | 56.78K | 0.53% |
| Fidelity NASDAQ Composite Index Fund | 17.45K | 0.16% |
| Fidelity Total Market Index Fund | 15.26K | 0.14% |
| Fidelity Series Total Market Index Fund | 12.90K | 0.12% |
Short interest
Settled Sep 30, 2026
- Shares short
- 133.88K
- Days to cover
- 1.00
- % of shares outstanding
- 1.25%
- Average daily volume
- 533.56K
- Change since last report
- +90.1%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.